NCT01703819View on ClinicalTrials.gov

Explorative Efficacy Profile of Neurexan® in an Experimental Acute Stress Setting in Healthy Subjects

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Acute Stress Reaction
Interventions
DRUG

Neurexan®

0.6 mg / tablet, 6 tablets, 1 tablet every 30 minutes from -180 minutes to -30 minutes

OTHER

Placebo

6 tablets, 1 tablet every 30 minutes from -180 minutes to -30 minutes

Trial Locations (2)

35032

Klinische Psychologie und Psychotherapie, Fachbereich Psychologie, Universität Marburg, Marburg

45122

Institut fur Medizinische Psychologie und Verhaltensimmunbiologie Universitatsklinikum Essen, Essen

All Listed Sponsors
lead

Biologische Heilmittel Heel GmbH

INDUSTRY

NCT01703819 - Explorative Efficacy Profile of Neurexan® in an Experimental Acute Stress Setting in Healthy Subjects | Biotech Hunter | Biotech Hunter